Home  >  News
News
  Milestone Pharma begins phase 3 clinical study of etripamil for termination of PSVT episodes,   August 13, 2018
  BeiGene begins phase 3 trial of tislelizumab in combo with chemotherapy to treat advanced squamous NSCLC,   August 13, 2018
  Sobi doses first patient in phase 1/2 study of SOBI003 to treat mucopolysaccharidosis type IIIA,   August 13, 2018
  JHL Biotech gets positive CHMP scientific advice for phase III trial of proposed trastuzumab biosimilar to treat breast cancer,   August 11, 2018
  Eurocine Vaccines announces positive result from phase I/II study of Immunose FLU,   August 10, 2018
  Sangamo reports positive data from phase 1/2 trial evaluating cDNA gene therapy candidate SB-525 for Hemophilia A,   August 10, 2018
  Sanifit completes enrollment in phase 2b CaLIPSO trial to treat CVC in ESRD patients on haemodialysis,   August 09, 2018
  United Therapeutics FREEDOM-EV clinical study o Orenitram to treat patients with PAH meets primary endpoint,   August 09, 2018
  Menarini Ricerche to sponsor phase I/II study in acute myeloid leukaemia in US,   August 08, 2018
  Karolinska Institutet to participate in Immunovia's PanFAM-1 study of early detection of pancreatic cancer using blood-based test,   August 07, 2018
  Britannia Pharma phase 3 TOLEDO study shows apomorphine infusion provides effective relief of persistent motor fluctuations in PD patients,   August 07, 2018
  Mologic starts clinical trial of urine-based diagnostic for cystic fibrosis,   August 04, 2018
  CalciMedica begins phase 2a study of CM4620 to treat patients with acute pancreatitis,   August 03, 2018
  RXi Pharma reports positive results from phase 1/2 trial with RXI-109 for retinal scarring,   August 02, 2018
  Neuralstem begins phase 2 trial of neural stem cell candidate, NSI-566 to treat ischemic stroke,   August 02, 2018
  Novo Nordisk announces positive results from PIONEER 3 phase 3a trial with oral semaglutide to treat type 2 diabete,   July 31, 2018
  Medivir reports positive top-line joint structure outcomes from MIV-711 osteoarthritis phase IIa extension study,   July 30, 2018
  NIH-funded study shows next-generation ALS drug silences inherited form of disease in animal models,   July 30, 2018
  CBT begins phase 1b trial for anti-PD-1 antibody CBT-501-01 to treat advanced solid tumours,   July 28, 2018
  Foresee Pharma completes phase 1 MAD trial with FP-045,   July 28, 2018

 Back
 
CPhI-WW-Banners-150X60-120618-anim-v2
CPhI_MEA_Banner_150x60_2018
cphikorea_150x60_saffron media
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |